Most not long ago, it's been recognized that conolidine and the above mentioned derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in similar areas as classical opioid receptors, it binds to a big selection of endogenous opioids. Contrary to most opioid receptors, this receptor functions for a scavenger and would not act